Short-term clinical outcome of stroke patients with or without prior statin treatment
- سال انتشار: 1400
- محل انتشار: فصلنامه تحقیقات جاری در داروسازی، دوره: 7، شماره: 1
- کد COI اختصاصی: JR_TIPS-7-1_005
- زبان مقاله: انگلیسی
- تعداد مشاهده: 334
نویسندگان
Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Objective(s): This study evaluated the impact of statin on the severity and outcome of stroke among patients who had taken it prior to the stroke onset and compared to patients who had not received it before the stroke. Methods: We included ۲۶۱ consecutive patients with acute ischemic stroke who admitted in Namazee hospital affiliated to Shiraz University of Medical Sciences from ۲۰۱۸-۲۰۱۹. We recorded demographic data, vascular risk factors, history of previous statin treatment, and National Institutes of Health Stroke Scale (NIHSS) score at time of hospital admission and modified Rankin Scale (MRS) ۳ months after stroke onset. The dependent variables were initial severity of stroke as measured by National Institute of Health Scoring System (NIHSS) and good outcome defined as modified Rankin Scale (MRS) ۰ to ۱. Results: Among ۲۶۱ patients with acute ischemic stroke, ۷۶ were using statins (۵۲.۶% of users were women). Among all the subjects, ۱۷۵ (۶۷.۶%) had history of hypertension, ۷۸ (۳۰.۱%) had history of diabetes mellitus, ۸۷(۳۳.۵%) had history of hyperlipidemia, ۶۳ (۲۴.۳%) were smokers. Admission NIHSS and MRS were not statistically different in statin users and non-statin users (P= ۰.۱۲ and P= ۰.۰۸, respectively). Adjusted Odds Ratios for poor functional outcome and ۹۰-day mortality according to previous statin use were ۰.۸۷ (۹۵% CI ۰.۳۷-۲.۰۵), P= ۰.۵۴) and ۰.۷۵(۹۵% CI ۰.۳۱-۱.۸۱, P= ۰.۵۲) which were not statistically significant. Conclusion: This study showed that pre-stroke statin therapy did not affect the initial clinical severity, short-term functional outcome and ۹۰-day mortality after ischemic stroke.کلیدواژه ها
Stroke, ischemic stroke, statinاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.